Concepedia

Publication | Closed Access

Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2

73

Citations

6

References

2018

Year

References

YearCitations

Page 1